The activities of Horizon Therapeutics Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Horizon Therapeutics Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
What is being lobbied?
Subject Matters
Health
Industry
Intellectual Property
Research and Development
Science and Technology
Subject Matter Details
Policies or Program
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Health Canada Regulatory Review of Drugs and Devices, including potential regulatory reforms with respect to drugs for rare diseases
Health system policies with respect to pharmaceuticals, including drugs for rare diseases
Innovation agenda led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences industry
Patented Medicine Prices Review Board (PMPRB) guidelines with respect to non-excessive pricing of patented medicines
Policies or Program, Regulation
Health Canada's Special Access Program (SAP) and associated regulations and guidelines
Regulation
Patented Medicine Prices Review Board (PMPRB) regulations with respect to non-excessive pricing of patented medicines
Who is being lobbied?
Government Institutions
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Communication techniques
Communication techniques that have been used or are expected to be used in the course of the undertaking: